168 related articles for article (PubMed ID: 37356274)
1. Utility of immunohistochemical expression of H3.3K36M and DOG1 in the diagnosis of chondroblastomas: An experience from a tertiary cancer referral center.
Rekhi B; Dave V; Butle A; Dutt A
Ann Diagn Pathol; 2023 Oct; 66():152174. PubMed ID: 37356274
[TBL] [Abstract][Full Text] [Related]
2. Anti-histone H3.3K36M Antibody is a Highly Sensitive and Specific Immunohistochemistry Marker for the Diagnosis of Chondroblastoma. A Validation Based on Study 136 Cases Comprising Chondroblastoma and its Mimics from Single a Centre in India.
Hui M; Uppin SG; Narayanan R; Kancherla NR; Kamble A; B RR; Patnala C
Int J Surg Pathol; 2023 Jun; 31(4):375-386. PubMed ID: 35786027
[No Abstract] [Full Text] [Related]
3. Immunohistochemical analysis of 36 cases of chondroblastomas: A single institutional experience.
Rekhi B; Ghate S; Shah A; Ramadwar M; Gulia A
Ann Diagn Pathol; 2020 Feb; 44():151440. PubMed ID: 31862519
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemistry for histone H3G34W and H3K36M is highly specific for giant cell tumor of bone and chondroblastoma, respectively, in FNA and core needle biopsy.
Schaefer IM; Fletcher JA; Nielsen GP; Shih AR; Ferrone ML; Hornick JL; Qian X
Cancer Cytopathol; 2018 Aug; 126(8):552-566. PubMed ID: 29757500
[TBL] [Abstract][Full Text] [Related]
5. Discovered on gastrointestinal stromal tumour 1 (DOG1): a useful immunohistochemical marker for diagnosing chondroblastoma.
Akpalo H; Lange C; Zustin J
Histopathology; 2012 Jun; 60(7):1099-106. PubMed ID: 22335248
[TBL] [Abstract][Full Text] [Related]
6. The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas.
Fang D; Gan H; Lee JH; Han J; Wang Z; Riester SM; Jin L; Chen J; Zhou H; Wang J; Zhang H; Yang N; Bradley EW; Ho TH; Rubin BP; Bridge JA; Thibodeau SN; Ordog T; Chen Y; van Wijnen AJ; Oliveira AM; Xu RM; Westendorf JJ; Zhang Z
Science; 2016 Jun; 352(6291):1344-8. PubMed ID: 27229140
[TBL] [Abstract][Full Text] [Related]
7. The incorporation loci of H3.3K36M determine its preferential prevalence in chondroblastomas.
Zhang Y; Fang D
Cell Death Dis; 2021 Mar; 12(4):311. PubMed ID: 33762579
[TBL] [Abstract][Full Text] [Related]
8. H3F3 mutation status of giant cell tumors of the bone, chondroblastomas and their mimics: a combined high resolution melting and pyrosequencing approach.
Kervarrec T; Collin C; Larousserie F; Bouvier C; Aubert S; Gomez-Brouchet A; Marie B; Miquelestorena-Standley E; Le Nail LR; Avril P; Christophe Pagès J; de Pinieux G
Mod Pathol; 2017 Mar; 30(3):393-406. PubMed ID: 28059095
[TBL] [Abstract][Full Text] [Related]
9. Mutation Analysis of H3F3A and H3F3B as a Diagnostic Tool for Giant Cell Tumor of Bone and Chondroblastoma.
Cleven AH; Höcker S; Briaire-de Bruijn I; Szuhai K; Cleton-Jansen AM; Bovée JV
Am J Surg Pathol; 2015 Nov; 39(11):1576-83. PubMed ID: 26457357
[TBL] [Abstract][Full Text] [Related]
10. Histone H3K36M mutation and trimethylation patterns in chondroblastoma.
Lu C; Ramirez D; Hwang S; Jungbluth A; Frosina D; Ntiamoah P; Healey J; Zhu G; Chen W; Klein M; Hameed M
Histopathology; 2019 Jan; 74(2):291-299. PubMed ID: 30098026
[TBL] [Abstract][Full Text] [Related]
11. Probe the function of histone lysine 36 methylation using histone H3 lysine 36 to methionine mutant transgene in mammalian cells.
Fang D; Gan H; Wang H; Zhou H; Zhang Z
Cell Cycle; 2017 Oct; 16(19):1781-1789. PubMed ID: 28129023
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of H3.3 G34W in 100 giant cell tumors of bone and its diagnostic mimics, including its value in resolving uncommon diagnostic scenarios: A single institutional study at a tertiary cancer referral center, India.
Rekhi B; Dave V; Butle A; Dharavath B; Khetale S; Redhu AK; Singh R; Dutt A
Indian J Pathol Microbiol; 2024 Feb; ():. PubMed ID: 38391356
[TBL] [Abstract][Full Text] [Related]
13. H3.3 K36M Mutation as a Clinical Diagnosis Method of Suspected Chondroblastoma Cases.
Mu H; Jiang Y; Xue L; Hua Y; Lin J; Cai Z
Orthop Surg; 2021 Apr; 13(2):616-622. PubMed ID: 33620145
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic characterization of malignant chondroblastoma: a neoplasm with locally aggressive behavior and metastatic potential that closely mimics chondroblastoma-like osteosarcoma.
Papke DJ; Hung YP; Schaefer IM; Bredella MA; Charville GW; Reith JD; Fletcher CDM; Nielsen GP; Hornick JL
Mod Pathol; 2020 Nov; 33(11):2295-2306. PubMed ID: 32601382
[TBL] [Abstract][Full Text] [Related]
15. Chondroblastoma: An Update.
Chen W; DiFrancesco LM
Arch Pathol Lab Med; 2017 Jun; 141(6):867-871. PubMed ID: 28557595
[TBL] [Abstract][Full Text] [Related]
16. Histone Mutations and Bone Cancers.
Taylor EL; Westendorf JJ
Adv Exp Med Biol; 2021; 1283():53-62. PubMed ID: 33155137
[TBL] [Abstract][Full Text] [Related]
17. The H3F3 K36M mutant antibody is a sensitive and specific marker for the diagnosis of chondroblastoma.
Amary MF; Berisha F; Mozela R; Gibbons R; Guttridge A; O'Donnell P; Baumhoer D; Tirabosco R; Flanagan AM
Histopathology; 2016 Jul; 69(1):121-7. PubMed ID: 26844533
[TBL] [Abstract][Full Text] [Related]
18. Distal Femoral Non-Epiphyseal Cortical Chondroblastoma Confirmed with
Gu H; Sun L; Cui J; Yu L; Wang J
Fetal Pediatr Pathol; 2023 Apr; 42(2):320-326. PubMed ID: 36048092
[No Abstract] [Full Text] [Related]
19. [Expression of H3.3 G34W mutant-specific antibody in giant cell tumors of bone and its diagnostic value].
Wang X; Wu N; Zhang RS; Wei X; Ji RH; Ma HH; Zhou XJ; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2020 Feb; 49(2):116-121. PubMed ID: 32074722
[No Abstract] [Full Text] [Related]
20. S-100 protein immunostaining in the differential diagnosis of chondroblastoma.
Monda L; Wick MR
Hum Pathol; 1985 Mar; 16(3):287-93. PubMed ID: 2579018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]